Skip to search formSkip to main contentSkip to account menu

Prostacyclin Receptor Agonist [EPC]

Known as: Prostacyclin Receptor Agonist 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 1. The metabolism of selexipag has been studied in vivo in man and the main excreted metabolites were identified. Also… 
2018
2018
Abstract 1. This study examined the pharmacokinetics, distribution, metabolism and excretion of the selective prostacyclin… 
2017
2017
BACKGROUND Selexipag is an orally available prostacyclin receptor (IP receptor) agonist with a non-prostanoid structure. In this…